- Sorted by date
- Hybrid Sort
- Smart Random Sort
- Sort by relevance
Advertisements
» Related Searches: patients, cancer patients, dialysis, dialysis corp, Patients
Results 11 to 13 of 13
New Data Show ACTOS Halted Progression of Atherosclerosis as Indicated …
Nephrology/ Dialysis News from StratCenter.com — 13th Nov 2006, 16:40 GMT
Results Demonstrated Significant Improvements on Cardiovascular Markers Beyond Glycemic
Control … 
- ├ New Data Show ACTOS(R) (pioglitazone HCl) Halted … — ArriveNet : Press Releases
- ├ Takeda Pharmaceuticals North America: New Data Show … — Market Wire - Medical and Healthcare
- ├ New data show ACTOS (pioglitazone HCl) halted … — EurekAlert! - Medicine and Health
- └ all 10 related »
Ruboxistaurin Reduced Vision Loss in Patients With Moderate to Severe …
Nephrology/ Dialysis News from StratCenter.com — 13th Nov 2006, 16:40 GMT
- Once Daily, Oral Investigational Therapy Reduced Sustained Moderate Vision Loss Over
Three-Year Period - …
- ├ Lilly: Arxxant cuts sight loss in diabetes — United Press International - Health Business
- ├ Lilly drug reduces blindness in diabetic patients — Pharmaceutical Business Review Latest News
- ├ Study Favors TAXUS Stent Over Cypher Stent … — Nephrology/ Dialysis News from StratCenter.com
- └ all 10 related »
Altus Pharmaceuticals Announces Presentation of ALTU-238 Phase II Data at …
Nephrology/ Dialysis News from StratCenter.com — 13th Nov 2006, 16:40 GMT
… patients with GI and metabolic disorders, announced the presentation of results
from its Phase II study of its product candidate ALTU-238 at The 3rd Int'l Congress of the
Growth Hormone …
- ├ - Webcast Alert: Isis Pharmaceuticals Announces Its … — Partnerships/ Joint Ventures News from StratCenter.com …
- ├ Spectrum Pharmaceuticals Announces Presentation of Ozarelix Data … — PR Newswire: All Releases
- ├ 1st Berlin Releases Research Update Following Callisto … — Pharmaceuticals News from StratCenter.com
- └ all 10 related »